
Gianluca Miglio
academicMale0.0Global Dominance: 0.00%
Gianluca Miglio is a pharmacology professor at the University of Turin, known for his research on cancer therapies and the disparities in drug approval between the European Medicines Agency (Ema) and the U.S. Food and Drug Administration (Fda). His recent study highlights how over half of cancer drugs are approved for slightly different patient populations on either side of the Atlantic, raising concerns about access to treatment based on geography.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Gianluca Miglio is a pharmacology professor at the University of Turin who discusses the differences in drug approval between the Ema and Fda.
Nuovi farmaci per i tumori, perché Europa e Usa prendono decisioni diverse una volta su due? E cosa cambia per i malati?Corriere della Sera·
Italy· 2025-04-14

